Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Kcnk10 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Kcnk10 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of KCNK10 mRNA | CTD | PMID:36331819 | Kcnk10 | Rat | 1,2-dichloroethane | decreases expression | ISO | Kcnk10 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of KCNK10 mRNA | CTD | PMID:28960355 | Kcnk10 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Kcnk10 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of KCNK10 mRNA | CTD | PMID:22206623 | Kcnk10 | Rat | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of KCNK10 mRNA | CTD | PMID:29097150 | Kcnk10 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Kcnk10 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of KCNK10 mRNA | CTD | PMID:26377647 | Kcnk10 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of KCNK10 mRNA | CTD | PMID:32109520 | Kcnk10 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of KCNK10 mRNA | CTD | PMID:32109520 | Kcnk10 | Rat | 4,4'-sulfonyldiphenol | affects methylation | ISO | Kcnk10 (Mus musculus) | 6480464 | bisphenol S affects the methylation of KCNK10 gene | CTD | PMID:31683443 | Kcnk10 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of KCNK10 mRNA | CTD | PMID:24780913 | Kcnk10 | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of KCNK10 mRNA | CTD | PMID:28959563 | Kcnk10 | Rat | aflatoxin B1 | increases methylation | ISO | KCNK10 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of KCNK10 gene | CTD | PMID:27153756 | Kcnk10 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of KCNK10 mRNA | CTD | PMID:16483693 | Kcnk10 | Rat | arachidonic acid | multiple interactions | ISO | KCNK10 (Homo sapiens) | 6480464 | Arachidonic Acid promotes the reaction [KCNK10 protein results in increased transport of Potassium] | CTD | PMID:16075240 | Kcnk10 | Rat | benzo[a]pyrene | increases methylation | ISO | KCNK10 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of KCNK10 exon | CTD | PMID:27901495 | Kcnk10 | Rat | benzo[a]pyrene | affects methylation | ISO | KCNK10 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of KCNK10 promoter | CTD | PMID:27901495 | Kcnk10 | Rat | Benzo[ghi]perylene | increases expression | ISO | Kcnk10 (Mus musculus) | 6480464 | 1,12-benzoperylene results in increased expression of KCNK10 mRNA | CTD | PMID:26377693 | Kcnk10 | Rat | beta-lapachone | decreases expression | ISO | KCNK10 (Homo sapiens) | 6480464 | beta-lapachone results in decreased expression of KCNK10 mRNA | CTD | PMID:38218311 | Kcnk10 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | KCNK10 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of KCNK10 mRNA | CTD | PMID:31163220 | Kcnk10 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Kcnk10 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of KCNK10 mRNA | CTD | PMID:34319233 | Kcnk10 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of KCNK10 mRNA | CTD | PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998 | Kcnk10 | Rat | bisphenol A | increases methylation | ISO | KCNK10 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of KCNK10 gene | CTD | PMID:31601247 | Kcnk10 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of KCNK10 gene | CTD | PMID:28505145 | Kcnk10 | Rat | butanal | increases expression | ISO | KCNK10 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of KCNK10 mRNA | CTD | PMID:26079696 | Kcnk10 | Rat | Butylbenzyl phthalate | increases methylation | ISO | Kcnk10 (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased methylation of KCNK10 intron | CTD | PMID:28392331 | Kcnk10 | Rat | carbon nanotube | decreases expression | ISO | Kcnk10 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of KCNK10 mRNA; Nanotubes, Carbon results in decreased more ... | CTD | PMID:25620056 | Kcnk10 | Rat | CGP 52608 | multiple interactions | ISO | KCNK10 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to KCNK10 gene] | CTD | PMID:28238834 | Kcnk10 | Rat | choline | multiple interactions | ISO | Kcnk10 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... | CTD | PMID:20938992 | Kcnk10 | Rat | cyclosporin A | decreases methylation | ISO | KCNK10 (Homo sapiens) | 6480464 | Cyclosporine results in decreased methylation of KCNK10 promoter | CTD | PMID:27989131 | Kcnk10 | Rat | diltiazem | multiple interactions | ISO | KCNK10 (Homo sapiens) | 6480464 | Diltiazem inhibits the reaction [KCNK10 protein results in increased transport of Potassium] | CTD | PMID:16075240 | Kcnk10 | Rat | dorsomorphin | multiple interactions | ISO | KCNK10 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Kcnk10 | Rat | entinostat | multiple interactions | ISO | KCNK10 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Kcnk10 | Rat | entinostat | decreases expression | ISO | KCNK10 (Homo sapiens) | 6480464 | entinostat results in decreased expression of KCNK10 mRNA | CTD | PMID:26272509 | Kcnk10 | Rat | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of KCNK10 mRNA | CTD | PMID:30307764 | Kcnk10 | Rat | flavonoids | decreases expression | EXP | | 6480464 | Flavonoids results in decreased expression of KCNK10 mRNA | CTD | PMID:18035473 | Kcnk10 | Rat | flufenamic acid | multiple interactions | ISO | KCNK10 (Homo sapiens) | 6480464 | Flufenamic Acid promotes the reaction [KCNK10 protein results in increased transport of Potassium] | CTD | PMID:16075240 | Kcnk10 | Rat | fluoxetine | affects response to substance | ISO | Kcnk10 (Mus musculus) | 6480464 | KCNK10 mRNA affects the susceptibility to Fluoxetine | CTD | PMID:23022515 | Kcnk10 | Rat | fluoxetine | increases expression | ISO | Kcnk10 (Mus musculus) | 6480464 | Fluoxetine results in increased expression of KCNK10 mRNA | CTD | PMID:23022515 | Kcnk10 | Rat | fluoxetine | decreases activity | ISO | Kcnk10 (Mus musculus) | 6480464 | Fluoxetine results in decreased activity of KCNK10 protein | CTD | PMID:23022515 | Kcnk10 | Rat | fluoxetine | multiple interactions | ISO | Kcnk10 (Mus musculus) | 6480464 | [KCNK2 mRNA co-treated with KCNK10 mRNA] affects the susceptibility to Fluoxetine | CTD | PMID:23022515 | Kcnk10 | Rat | folic acid | multiple interactions | ISO | Kcnk10 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... | CTD | PMID:20938992 | Kcnk10 | Rat | furan | decreases expression | ISO | Kcnk10 (Mus musculus) | 6480464 | furan results in decreased expression of KCNK10 mRNA | CTD | PMID:24183702 | Kcnk10 | Rat | genistein | increases expression | ISO | Kcnk10 (Mus musculus) | 6480464 | Genistein results in increased expression of KCNK10 mRNA | CTD | PMID:32186404 | Kcnk10 | Rat | glycidol | decreases expression | EXP | | 6480464 | glycidol results in decreased expression of KCNK10 mRNA | CTD | PMID:24395379|PMID:24915197 | Kcnk10 | Rat | halothane | multiple interactions | ISO | KCNK10 (Homo sapiens) | 6480464 | Halothane promotes the reaction [KCNK10 protein results in increased transport of Potassium] | CTD | PMID:16075240 | Kcnk10 | Rat | inulin | multiple interactions | ISO | Kcnk10 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of KCNK10 mRNA | CTD | PMID:36331819 | Kcnk10 | Rat | L-methionine | multiple interactions | ISO | Kcnk10 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation more ... | CTD | PMID:20938992 | Kcnk10 | Rat | mefenamic acid | multiple interactions | ISO | KCNK10 (Homo sapiens) | 6480464 | Mefenamic Acid promotes the reaction [KCNK10 protein results in increased transport of Potassium] | CTD | PMID:16075240 | Kcnk10 | Rat | mercury dibromide | decreases expression | ISO | KCNK10 (Homo sapiens) | 6480464 | mercuric bromide results in decreased expression of KCNK10 mRNA | CTD | PMID:26272509 | Kcnk10 | Rat | mercury dibromide | multiple interactions | ISO | KCNK10 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Kcnk10 | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of KCNK10 gene | CTD | PMID:35440735 | Kcnk10 | Rat | methylmercury chloride | decreases expression | ISO | KCNK10 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of KCNK10 mRNA | CTD | PMID:28001369 | Kcnk10 | Rat | N-methyl-4-phenylpyridinium | decreases expression | ISO | KCNK10 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of KCNK10 mRNA | CTD | PMID:24810058 | Kcnk10 | Rat | Niflumic acid | multiple interactions | ISO | KCNK10 (Homo sapiens) | 6480464 | Niflumic Acid promotes the reaction [KCNK10 protein results in increased transport of Potassium] | CTD | PMID:16075240 | Kcnk10 | Rat | p-chloromercuribenzoic acid | decreases expression | ISO | KCNK10 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of KCNK10 mRNA | CTD | PMID:26272509 | Kcnk10 | Rat | p-chloromercuribenzoic acid | multiple interactions | ISO | KCNK10 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Kcnk10 | Rat | panobinostat | multiple interactions | ISO | KCNK10 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Kcnk10 | Rat | panobinostat | decreases expression | ISO | KCNK10 (Homo sapiens) | 6480464 | panobinostat results in decreased expression of KCNK10 mRNA | CTD | PMID:26272509 | Kcnk10 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Kcnk10 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of KCNK10 mRNA; [perfluorooctane sulfonic more ... | CTD | PMID:36331819 | Kcnk10 | Rat | phenylmercury acetate | decreases expression | ISO | KCNK10 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of KCNK10 mRNA | CTD | PMID:26272509 | Kcnk10 | Rat | phenylmercury acetate | multiple interactions | ISO | KCNK10 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Kcnk10 | Rat | pirinixic acid | increases expression | ISO | Kcnk10 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of KCNK10 mRNA | CTD | PMID:20813756 | Kcnk10 | Rat | potassium atom | multiple interactions | ISO | KCNK10 (Homo sapiens) | 6480464 | Arachidonic Acid promotes the reaction [KCNK10 protein results in increased transport of Potassium]; Diltiazem inhibits more ... | CTD | PMID:16075240 | Kcnk10 | Rat | rotenone | decreases expression | ISO | KCNK10 (Homo sapiens) | 6480464 | Rotenone results in decreased expression of KCNK10 mRNA | CTD | PMID:29955902 | Kcnk10 | Rat | SB 431542 | multiple interactions | ISO | KCNK10 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Kcnk10 | Rat | sodium arsenite | multiple interactions | ISO | KCNK10 (Homo sapiens) | 6480464 | [sodium arsenite affects the acetylation of H3-4 protein] which affects the methylation of KCNK10 promoter | CTD | PMID:18448484 | Kcnk10 | Rat | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of KCNK10 mRNA | CTD | PMID:35314868 | Kcnk10 | Rat | sodium arsenite | increases expression | ISO | KCNK10 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of KCNK10 mRNA | CTD | PMID:34032870 | Kcnk10 | Rat | sodium arsenite | affects methylation | ISO | KCNK10 (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of KCNK10 gene | CTD | PMID:28589171 | Kcnk10 | Rat | titanium dioxide | increases methylation | ISO | Kcnk10 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of KCNK10 gene | CTD | PMID:35295148 | Kcnk10 | Rat | trichostatin A | decreases expression | ISO | KCNK10 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of KCNK10 mRNA | CTD | PMID:24935251|PMID:26272509 | Kcnk10 | Rat | trichostatin A | multiple interactions | ISO | KCNK10 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Kcnk10 | Rat | valproic acid | increases expression | ISO | KCNK10 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of KCNK10 mRNA | CTD | PMID:23179753 | Kcnk10 | Rat | valproic acid | affects expression | ISO | KCNK10 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of KCNK10 mRNA | CTD | PMID:25979313 | Kcnk10 | Rat | valproic acid | decreases expression | ISO | KCNK10 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of KCNK10 mRNA | CTD | PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369 | Kcnk10 | Rat | valproic acid | multiple interactions | ISO | KCNK10 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















